The first Australian study of primary sclerosing cholangitis (PSC) has confirmed a high rate of gastrointestinal malignancy especially in patients who also have inflammatory bowel disease (IBD). The retrospective study of 208 patients from two tertiary referral hospitals in Sydney found 22% of patients with both PSC and IBD developed cancers including cholangiocarcinoma, colorectal adenocarcinoma ...
Cancer risk confirmed in primary sclerosing cholangitis
By Mardi Chapman
7 Dec 2016